Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
p/s 2
That won't be necessary. We don't need roofers with driver's rage. We already have a leader in Zac. Besides, your role model is too busy thumping his chest somewhere.
Not only is a college education a requirement, but we have entrenched experience as a bonus. So, your 10,000 shares I have you down for at .13 is safe and sound. No worries.
I'll break it down for you since my clarity on this company has never been better. A lot of my questions can be extrapolated from the given data. Don't really need Zac's answers. But his silence on the issues speaks loudly. Those are concerns out there, and very valid ones.
Our recurring revenue is everything that we have. All organic from here. Just don't lose business. Gain it only on the net. They gave us nice graphics. This company is on track to hit $14M this year. But backing out security the first half, our new business software model is on track for $11M easily. That would put us at a real adjusted P/S of 2 at end of this year at today's pre-diluted price.
All they have to fix are the issues they are silent on, and that's a work in progress. The numbers are there. The ball is in their court, and I'm sure they want to run it all the way down the field. It's more clear than ever before, and I've never felt better about this company before. I have so many good stocks, that it matters not who has a run first. The runners will feed the other crops, and it will be an abundant harvest. Because we reap what we sow. IFF you know what you are doing, that is.
This business is now more scaleable than ever before, and they are headed towards profitability. The snowball has started its roll, and it will only get bigger and bigger from here.
That's why we are going to keep Zac in favor of the clueless.
The CSE
So I think we got 2 of our 10 questions somewhat answered. Well, at least he read them. And it was fun coming up with them and part of the Helix adventure. So, even if he didn't get to them all, he at least got to hear our input and concerns.
I think his answer about the CSC, however, is a transcriptionist error. I think what I heard was CSE because that's what I know when I think of the Canadian stock exchange. That's the Canadian Stock Exchange, and I recall Helix mentionining Sedar back then. I mentioned Sedar in my question, so he's skimming and paraphrasing me. Not htat it really matters, but the CSE is for small caps but has minimal capital requirements and higher standards than the small cap Sedar. And at the CSE, I love it because you have to fill out and submit a small Q&A every single month. And their regulation is much more respectable than our OTC. OTC is good, but Sedar is better, and CSE is even better than that in my opinion. As far as regulation and reporting standards go. And I like their format better, such as the MD&A. Not necessarily better liquidity over there.
This is what got transcribed:
We did have a plan to go into the CSC. And essentially we offer that plan just because of the market conditions at that time. So as an example now, given where cannabis capital markets are today if we were looking to list let's say on the OTC, which were already listed on the OTC, but were we to do that today, we would probably say no, we want to wait because we felt that the market conditions were tight and we're going to be a great benefit to the company.
So that same scenario essentially happened back then. There were certain assumptions that we had. That didn't seem - and it didn't seem like the right thing to do at that time was continue with CSC listening.
Now that said, we continue to evaluate all possibilities for increasing our shareholder value and liquidity to include listing on a different exchange sometime in the future or an additional exchange sometime in the future. And we'll make the appropriate announcements when the time comes.
So, there's that. He didn't ever get back to this statement he said in Q1: "And we're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call.."
Oh, well. I don't think he reported on that. But at least no rude people on this call. And, I partly blame myself for not pressing that answer, but it's hard enough to work and listen at the same time. Nice of them to put out a transcript within one hour. Very consistent on that. Unlike NROM whose transcript may get shredded or might get posted days later. You never know.
That was a nice call.
I got to listen in as I work at the same time, so I only half-way heard it. They didn't get to my questions but one. I guess they were too controversial. The story of my life. But that's okay. It was a good call and good quarter. The truth comes out of the shake, no matter what.
And, then, we have the D-table over there, acting up as usual.
So, this is what driver's rage looks like, folks. Below. He has a horn, and he's going to use it!!! But one day, he's going to honk at the wrong person.
The graphic on the investor deck does show Helix Security. But it only describes itself as system design and install and video monitoring.
So, in a prior post I said that I'm not sure if systems installation was included in the sale of Helix Securities. I *assumed* that it would be because it sounded like it would be a part of it. But it looks like I assumed wrong if I understand the forward-looking nature of this graphic correctly.
So I guess we sold only the guard and we have a "Helix Security" now in a less labor intensive way. No S.W.A.T, just tech. Perhaps that's why we changed our name to Helix Technologies. . It's our smallest revenue contribution, only looking at about $400,000 per year from that segment.
But it could grow to be more meaningful and more focus can be focused there now.
HLIX Investor Deck from 8k
Helix released an 8k with that PR. It has an investor deck in it, which they are going to use in the conference call tonight and use in future meetings it says:
https://www.otcmarkets.com/filing/html?id=14339281&guid=VMP6UarWJBXu0th#EA125597EX99-2_HELIXTECHNO_HTM
Nice. I like graphics. Professionalism like at KERN.
Q2 Cash Flows, Emerald:
I'm not sure where they are pulling this from, Emerald:
Posted Q2 Cash Flows from Operations of $446k, a 162% improvement from Q2 2019
Do you know where that's coming from? They don't break it out in Q2, but that's what they are saying in their financial highlights of the PR today.
I'm not complaining. That's very good. Just as I said it would have to be in order to squeak out a small increase for the first 6 months. That's very good. That's undeniably cash flow positive from operations alone. Dilution, however, does dilute that. And it hurts. Toxic. Needs a strong anti-dillutive base. I see only one other big conversion coming up in September this year, which has potential to be sidestepped.
And then this is very encouraging:
"Exceeded 200 Cannalytics clients, more than doubling users in just one quarter"
I'm assuming that's revenue producing. They never actually say. It has to be very good margins when you already have the internal data, that's just growing with each market share grab. Cannabase's data in their too, I'm sure.
I hope they answer the question and break those numbers out. A doubling is really good. I'd like that to be an exponential trend.
HLIX PR on Financial Highlights:
https://seekingalpha.com/pr/17973749-helix-technologies-q2-2020-results-record-revenues-positive-cash-flows-from-operations-and
"Those who have been following Helix Technologies know that we have always focused on the disciplined execution of our strategic plans, without fanfare or hype. We continue to deliver value to our expanding client base as their critical infrastructure partner, even as we continue to grow our organic market share and roll out new products in response to customer needs" said Helix Technologies CEO and Executive Chairman Zachary L. Venegas. "In a business and capital market environment that has at times ignored our constantly improving metrics and growing market share, we have stayed the course and achieved all of our 2020 financial goals already--setting the stage for an outstanding and exciting rest of the year. I can assure you that we are only getting started."
Highlights of Q2 and H1 2020 Include:
Grew first half revenue to $9.3mm, a 28% increase over H1 2019
Improved first half gross profit 39% to $4.7mm
Increased Software Gross Profit to $3.9mm in the first half, a 38% increase from 2019
Generated Software Adjusted EBITDA1 of $1.6mm in H1 2020, a 29% margin
Overall Adjusted EBITDA for H1 improved over $2mm from 2019 to $259k
Software revenue increased 20% from H1 2019 to $5.4mm, despite the Coronavirus outbreak and associated market headwinds
Improved quarterly Software Gross Margin to 74%, a 17% improvement from Q2 2019
Posted Q2 Cash Flows from Operations of $446k, a 162% improvement from Q2 2019
$2mm in cash at the end of Q2, a 300% increase from Q4 2019
Launched Cannalytics Cultivation Platform, the first of its kind in the industry
Exceeded 200 Cannalytics clients, more than doubling users in just one quarter
Continued to expand the Helix ecosystem by adding new integration partners
The second quarter of 2020 was a landmark for Helix Technologies, reaching the critically important milestone of positive cash flow from operations, further distinguishing us from the rest of the industry. While companies across all sectors and industries were reeling from the Covid-19 pandemic, Helix's focus on operations, innovation, and strategic execution allowed us to post positive operating results."
Final Submission:
So 7 days gone by. If you haven't gotten your questions in by now, you'll have to submit your own.
Good quarter. Good business in a good industry. Bad shareholder value. Ugly financing. Some alignment of interests. Sounds like a good contrarian investment if you ask me.
I will present this within the next few minutes as the work product of a few shareholders.
____________________________________________________
1) A year or so ago, there was mention of a dual listing on the Sedar stock exchange in Canada. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
2) Can you give us an idea of how much Cannalytics and Amercanex are contributing in revenue at this time? They aren't broken out, and I'm wondering if a rough estimate could be given as to what each one of those contributes in terms of sales in Q2.
3) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
4) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. And between December 31 of 2019 and June 31, 2020, the OS increased by 9 million shares due to convertible note conversions. I worry about excessive dilution at these prices, but what is your thoughts on that? Am I looking at it wrong, and how do you see the future in terms of that? Would improved financing be able to consolidate all of the outstanding notes into one, simple financing package in the future?
5) Would it be fair to say that MJ Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
6) Does Helix have plans to uplist in the future? Akerna (KERN) seems to have gotten on the Nasdaq by way of a SPAC. If so, do you have a plan, as it's my understanding that we do not currently meet the requirements? And would a reverse split ever be considered in such a plan?
7) Can you shed any light on what the sale of the guard side of Helix would mean to your bottom line, and will that be reflected in the next quarter? Do you have a projection of what your gross revenue and margins will look like at years' end without the security business?
8) How much of your revenue is recurring, and what are your recurring growth expectations?
9) In the last 8K in regard to the sale of Helix Security, it's my understanding that Invecta assumes most of its liabilities with the exception of some pending lawsuits against the company. Do I understand that correctly? It also notes that they do not assume "matters referenced in that certain letter dated January 7, 2020, from Michael P. Kane to Grant Whitus regarding a shooting at STEM School Highlands Ranch on May 7, 2019." Could you shed some light on what that's about?
10) There's a 10b5 program in place, which automatically sells insider shares over a period of time, overseen by a neutral party. Some people see those Form 4's and get the wrong message, thinking insiders don't believe in the company. They see a large amount of form 4's, even though the overall tally is small. Are you able to say how long that will continue? I understand that you should reap the fruits of your labor, but just wondering if you feel it may send the wrong messaging out there?
Correction:
I said:
Seems like Scott Ogur is rewarding himself for diluting you.
1) On February 21, 2020 the Company awarded the Chief Financial Officer, an option to purchase a total of 200,000 shares of the Company’s common stock at a price of $0.385 per share. These options vested immediately upon grant and expire on February 21, 2025.
MY COMMENTARY: I don't know how he earned that. But that's equal to my avg. share cost to the penny almost. So I like that alignment of interests.
My cost avg is .29 according to Etrade. So he actually can buy ABOVE my cost. Not equal. That's even better. Good! Punishment! It should be that way. It should ALWAYS be that way. It should be regulated that way. Did you hear that, Steve Janic? REGULATED that way. I don't know if you can handle a real stock exchange, Janic, because they are more REGULATED. Regulation is good. Helix, like you, obviously need regulation.
Scott buys higher than my cost average IFFFF he can perform and stop diluting shareholders. I liked his conversions when they were up there above .90. However, Scott, you gave them a loophole to go toxic under .90 should the stock drop under that. You didn't anticipate, I suspect. But it happened. Because of a rush to the exit by greedy people like Cannabase and Biotrack insiders that only cared about themselves as I see things. They just wanted to be millionaires and don't care about anything else.
And then ZAC's .16 options, equal to today's price, doesn't vest immediately like Scott's. They vest over a number of years, which is good. Restricted. Hands tied on those at least. Mine, however, are freely tradeable. As it should be. NOBODY should eat unless I eat first. And unless Global eats first. And unless Emerald EATS FIRST.
And that includes you, Steve Janic. You better work hard for these shareholders with OUR money. And put your mouth with your rhetoric because some of us around here WORK for our money, despite what your self-induced brainwashing rhetoric would say otherwise. The propaganda you spout is a manifestation of your ignorance, so stick to what you know and WORK on shareholder value.
Grant Whitus, don't let the door slam you on your #$# on the way out . Your views on the world are upside down. You stick to what you know too . Which is security. You know that. Everything else spewing out of your mouth is vacuous nonsense.
The fools never knows who they are. Just put up and shut up! All of you!
Seems like Scott Ogur is rewarding himself for diluting you.
1) On February 21, 2020 the Company awarded the Chief Financial Officer, an option to purchase a total of 200,000 shares of the Company’s common stock at a price of $0.385 per share. These options vested immediately upon grant and expire on February 21, 2025.
MY COMMENTARY: I don't know how he earned that. But that's equal to my avg. share cost to the penny almost. So I like that alignment of interests.
2) On June 19, 2020 the Company awarded the Chief Executive Officer, an option to purchase a total of 500,000 shares of the Company’s common stock at a price of $0.167 per share. These options vest over a three-year period from June 19, 2021 to June 19, 2023 and expire June 19, 2025.
MY COMMENTARY: I don't like that. And I don't know how he earned that either. That's the price today. So, one could buy today and have the same benefit as Zac. Only, his come with zero risk. But, that is an alignment of interest which is good. Or, an indirect way of just giving himself all those free Form 4's so he didn't even lost any quanity.. Only, he seems to be able to grant himself anything at anytime at your cost. That's why, it's best to be in alignment and put the wind on your back. The first half of this year has been going against severe headwinds. Toxic dilution, selling from all those that were bought, etc., etc.
Luckily, it's my understanding that Steve Janjic's hands are tied. So he needs to shine. His political views are the same as the Chinese lady that can't give birth, as well as Grant Whitus's views. Which are extreme, ignorant, and out of touch with reality. Which would explain probably a letter, a beating, and a spanking they all received and rightly so. Oh, and Seigels' views way, way out there with all of their's as well. Extremism, like terrorist mentality. All feeling very Holier than thou. Which is always a function of ignorance.
So now that they are all under water, and our CFO has realigned himself with us, I would say it's pretty good sailing I hope. Not perfect. And Toler has a good background. I would not go long above .60. While they do have a lot of warrants up there, there are lots of exercisable #$#@ below. Unless everything gets refinanced. There are some good motives at .32 as well in the Series B Preferred given to accredited investors back in 2017. But they have good anti-dilution clauses which you guys don't get, so dilution matters not to them. However, they hover around a good .32 price which is 100% avbove his price.
Legal theft of 8,909,831 shares.
Between December and end of June, 8,909,831 flooded the OS due to conversions. Had the stock price been at $1, that would have been an acceptable 1M. In 2018 up to December of 2019, only a small 155,000 shares converted. Of course at $3.00, which was admittedly a very expensive price and can't be justified from a value perspective yet, that's a good half grand of debt erased. Therefore, I have to modify Question 3 just a bit.
1) A year or so ago, there was mention of a dual listing on the Sedar stock exchange in Canada. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
1A) Can you tell give us an idea of how much Cannalytics and Amercanex are contributing in revenue at this time? They aren't broken out, and I'm wondering if a rough estimate could be given as to what each one of those contributes in terms of sales in Q2.
2) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
3) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. And between December 31 of 2019 and June 31, 2020, the OS increased by 9 million shares due to convertible note conversions. I worry about excessive dilution at these prices, but what is your thoughts on that? Am I looking at it wrong, and how do you see the future in terms of that? Would improved financing be able to consolidate all of the outstanding notes into one, simple financing package in the future?
4) Would it be fair to say that MJ Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
5) Does Helix have plans to uplist in the future? Akerna (KERN) seems to have gotten on the Nasdaq by way of a SPAC. If so, do you have a plan, as it's my understanding that we do not currently meet the requirements? And would a reverse split ever be considered in such a plan?
6) Can you shed any light on what the sale of the guard side of Helix would mean to your bottom line, and will that be reflected in the next quarter? Do you have a projection of what your gross revenue and margins will look like at years' end without the security business?
7) How much of your revenue is recurring, and what are your recurring growth expectations?
8) In the last 8K in regard to the sale of Helix Security, it's my understanding that Invecta assumes most of its liabilities with the exception of some pending lawsuits against the company. Do I understand that correctly? It also notes that they do not assume "matters referenced in that certain letter dated January 7, 2020, from Michael P. Kane to Grant Whitus regarding a shooting at STEM School Highlands Ranch on May 7, 2019." Could you shed some light on what that's about?
9) There's a 10b5 program in place, which automatically sells insider shares over a period of time, overseen by a neutral party. Some people see those Form 4's and get the wrong message, thinking insiders don't believe in the company. They see a large amount of form 4's, even though the overall tally is small. Are you able to say how long that will continue? I understand that you should reap the fruits of your labor, but just wondering if you feel it may send the wrong messaging out there?
HLIX on Tuesday after Conference Call:
They'll be here at the The JMP Securities Cannabis Technology Forum.
https://www.jmpg.com/jmp-securities/conferences/
August 18th. Press "View Invitation."
KERN will be there too. Those bas#%#@Ds!!
It was brought to my attention earlier today, after being flagged at Seeking Alpha. It popped up a notification on my Iphone since I follow HLIX at Seeking Alpha:
https://seekingalpha.com/article/4368964-stocks-to-watch-walmart-target-kandi-and-gold-vs-bitcoin
______________________________________________
Question Tally for Monday thus far, before renumbering:
1) A year or so ago, there was mention of a dual listing on the Sedar stock exchange in Canada. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
1A) Can you tell give us an idea of how much Cannalytics and Amercanex are contributing in revenue at this time? They aren't broken out, and I'm wondering if a rough estimate could be given as to what each one of those contributes in terms of sales in Q2.
2) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
3) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. I worry about excessive dilution at these prices, but what is your thoughts on that? Am I looking at it wrong, and how do you see the future in terms of that? Would improved financing be able to consolidate all of the outstanding notes into one, simple financing package in the future?
4) Would it be fair to say that MJ Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
5) Does Helix have plans to uplist in the future? Akerna (KERN) seems to have gotten on the Nasdaq by way of a SPAC. If so, do you have a plan, as it's my understanding that we do not currently meet the requirements? And would a reverse split ever be considered in such a plan?
6) Can you shed any light on what the sale of the guard side of Helix would mean to your bottom line, and will that be reflected in the next quarter? Do you have a projection of what your gross revenue and margins will look like at years' end without the security business?
7) How much of your revenue is recurring, and what are your recurring growth expectations?
8) In the last 8K in regard to the sale of Helix Security, it's my understanding that Invecta assumes most of its liabilities with the exception of some pending lawsuits against the company. Do I understand that correctly? It also notes that they do not assume "matters referenced in that certain letter dated January 7, 2020, from Michael P. Kane to Grant Whitus regarding a shooting at STEM School Highlands Ranch on May 7, 2019." Could you shed some light on what that's about?
9) There's a 10b5 program in place, which automatically sells insider shares over a period of time, overseen by a neutral party. Some people see those Form 4's and get the wrong message, thinking insiders don't believe in the company. They see a large amount of form 4's, even though the overall tally is small. Are you able to say how long that will continue? I understand that you should reap the fruits of your labor, but just wondering if you feel it may send the wrong messaging out there?
Recap on Engini:
I believe this is our Engeni software company:
http://www.engeni.com/index-en.html
Not much information is given, or even where they are located. Although, its purpose seems to serve as our own internal IT dept. more than anything. As an internal tech consultant to my eyes. People to call on for strategic advice, will they be able to merge such and such, can you upgrade this if we take it on? So on and so on. What lies ahead for them? What is Zac's next goal?
While the website doesn't give a location, a former PR of ours says it's located an "Argentinian firm, located in Buenos Aires"
Just to go back to our purchase of it:
https://mjobserver.com/united-states/helix-tcs-acquires-software-development-firm-engeni-s-a/
"Engeni, SA is a software development firm that provides software solutions for small and medium businesses. The company serves clients throughout the Americas including Argentina, Mexico, Peru and the United States. Engeni leverages the latest developments in technology to deliver maximum value to the small and medium business market."
While no link exists on that PR, at the very bottom of the Engeni website above, in tiny print, is "Engeni SA"
In totality, HLIX paid 1 million shares of that company. No details were released in the PR, but they are in our filings. All these people, like Jennifer of Cannabase -- they all want to cash out when their shares are not restricted. They all want to be millionaires and just can't wait to exit. Some willign to give their shares to others for a cheaper price, just to get to the exit first. All for their own self interests. The greed and deception of mankind. And if they are religious, which virtually all manipulators are, that just goes hand in hand. But at the same time, it's good to take advantage of their greed and folly and manipulate the manipulators. That's Mr. Market, after all.
And when you have toxic conversions goign on at the same time, I think that it's not good physics. And I don't think this kind of behavior was limited to only Helix in the Cannabis industry, so you have that as a contributor to the entire industry's fall. I think these prices, however for Helix, dilution aside for now, is decent price.
Interesting. And they were "partners" with Zac's security project since 2017 according to that PR. Probably had developed Zac's security software for HELIX TCS when they were just security.
It's pretty interesting, the way Zac's mind works. I do like his strategic thinking.
You do have losses, Emerald:
That was a cut and paste:
Security and guarding
Q1 EBITDA = -$726k
Q2 EBITDA = -$375k
My apologies. There was nothing to clear up.
You have tiny, itsy bitsy, little negative signs in front of those. I can't even seen those, hardly. I need glasses! I need to go take advantage of my Vision insurance before the year is up. For real.
So all 3 lawsuits remain. They "previously accrued a $440,000 liability" related to the first case that settled, pending approval and the outcome of the second case.
On July 29th, after this quarter, they paid $336,000 (includes interest), paying of a note in full that was extended last year. That's good no conversions came with it. Althought, it wasn't a convertible note either. I hate conversions at this share price. That should never be allowed again. We have the stability to never be at the mercy of anyone. Don't pursue anything ever again without solid financing on good terms!
More than anything, I want somebody like Corbel Capital to come in and offer a large capital infusion to pay off all liabilities, lower interest rate, and goals set with warrants priced far above our heads for goals met.
But overall, this is looks pretty good with dilution being a wild card to me. Another 7 months to get through all of that murkiness to my understanding at this time.
Thanks for breaking those out, Emerald!
Just to be clear, these are losses:
Security and guarding
Q1 EBITDA = -$726k
Q2 EBITDA = -$375k
Should be in () but, yes, I know what you mean. Numbers are accurate. I can't wait to dive in tomorrow when I have time.
Why don't you pose some questions. I appreciate you! Just, not about Form 4's, please. They answered. It's not a big deal. But you have a lot to contribute! And, everybody lies. Especially white lies. So, the logic doesn't necessarily follow that if you aren't straight on the small things then you'd be crooked on the big things. The whole Form 4 thing is just not professional. I have a question on it, but I don't particularly like it. That's why it's the last question on the list. ;)
But the software is definitely EBITDA positive. That's a good business. I liked the guard too. It was clearly still moving in the right direction. I did like the whole security suite offering. I don't know that $1.4M sounds like a whole lot for that... How do you feel about that price?
I'm not sure if that systems installation goes with it. I'm assuming it does. It sounds like it would be part of Helix Security.
So I have 2 questions I need to add later. Note to self:
1 about cannalytics contribution
2 about cash flows in Q2 broken out
Oh, and you know what else I like? It's never talked about. But I like having our own little software company Engini down there in South America somewhere. Our own internal IT dept. Upgrading Biotrac. And, they do outside sales as well. Not a big conribution to that, but it wasn't a big price tag. And, I just like it...
In hindsight, It seems to me Zac had a plan when he purchased it to be an integrator. They work as an internal consultant for merging techs too. I'm sure they played a big role in merging Amercanex and Cannalytics into Biotrack... And what is in store for them to do?
Amercanex Integration.
You said, " Mgmt has not spoken about the progress of next-gen biotrack, americanex or analytics"
I found this excerpt (some sections removed) to be highly interesting.
We have largely completed the financial and operational integrations of the previous 24 months, namely the acquisitions of BioTrackTHC, Engeni, Tan Security and Amercanex...
... Engeni has also become the Company’s organic offshore software development platform, and has delivered the second generation of the BioTrackTHC software...
...The Company has integrated Amercanex’s technology with BioTrackTHC’s software platforms. Integration of the previously announced acquisitions has already yielded the operational and financial results that the management team sought, evidenced by strongly improved cash flows from operations, growing market share, and a greatly accelerated software development time with increased market responsiveness.
These integrations still have room to yield more financial and operational leverage, which will be welcome in the unprecedented operating environment that now confronts the industry. Further, the turnaround of the BioTrackTHC unit is well advanced, with strategic restructuring in operations and personnel nearly complete, having been initiated in 2019. The transition of BioTrackTHC from an operation with negative $800,000 of Adjusted EBITDA in 2018 (while still better than competitors) into an operation that generated nearly $800,000 in Adjusted EBITDA in Q1 2020 and Q2 2020 is a transformational success.
Fascinating!
Of course, Tan was part of Helix Security and was sold. I like this company. I just don't like that conversion loss in the statement of cash flows. I don't like this price for conversions. But at the same time, it gave me a 40,000 share position at average of cost of .29.
As for your cannalytics, which I'm curious about too, it also says this in there:
Lastly, the Company generates monthly recurring revenues from Cannalytics, its business intelligence and data tool for commercial customers. Revenue is recognized monthly.
There is nothing else in there about it. I don't know how to break that out. That's a good question to add right there!
I'm going to have to move that question up to the top. If they go in order of priority, I want that to be addressed. Form 4's at the bottom. Sorry, no offense.
Your Predictions Exceeded
Wow. They did it! They squeaked out positive cash flow from operations alone. First time ever. Whew! I love that. I want to know what it was for just this quarter though. I don't see that. That has to better.
They had an increase in sales across all sectors, again. Not level as you imagined. This is good. If they can remain positive from operations alone, which seems much more probable without a security that's labor intensive, they may be more in alignment with my expectations.
That guard is was good too. That's going to be a big hit in sales, but hopefully expands our sails. They dramatically reduced their G&A too. I'm just barely glancing as I have to get back to work, but that's good on the surface. Have $2M in cash. And that's before the sale of Helix Security.
I'm only worried about dilution at this point. Thank you, Zac and team! They can be self-sustaining now, without the need of going to the market if all things remain in motion and the law of inertia holds up without some outside force acting upon it. Unless they want to do anotheer power grab. But I say let's coast a bit. I think the ball is in their court now for financing. I want to see all this crap refinanced at better terms.
KERN is Falling Like a Rock On Jupiter
Kern has been in a downward trajectory all month. Please don't dissapoint, Helix. Please let me go metaphorically punch some KERN shareholders in the mouth this weekend. Just give me a good reason to go over there.
And also, the confused cannabis analyst, Alan. I have a special-needs program in store for him.
KERN, falling to 80M pre-dilution. HLIX rising to 17M pre-dilution. How will it end?
We have till Monday.
I was going to submit our questions this morning, but we have the weekend too:
Company will host a conference call at 4:30 p.m. eastern time on Monday, Aug 17th to discuss the financial results and the Company's positioning for growth for the remainder of 2020 and beyond. There will be a live Q&A following the presentation portion of the call. Investors are also encouraged to submit questions via email prior to and during the call by emailing ir@helixtechnologies.com
Just Q3 today. No reason to rush if we have time. Like Biden's extraordinary pick for VP. A prosecutor well vetted for dealing with narcissistic predators. The one I was hoping for! Best to wait for last minute. Never know. Might think of something else.
And, yes, send me Pat's website link, Whatsp. I can't find it on a Google search. I'll submit some questions to him as well. Or is this website another figment of your imagination?
Perhaps you would like to see the birth pangs up close and personal?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156454811
It's very relevant to HLIX. Because I think this lady needs a C-Section. HLIX is very well adept in these matters. Like Dr. Helix. Is there a doctor in the house? Yes. Unfortunately, it's like pre-Uber days. You have all these cars and no rides. I just need somebody that knows what they're doing to pull this lady out!
Heck, HLIX can have a new side business. KERN has consulting. We can have an app for people that need to go public on the fly. HLIX does it fast, in just a few months. They don't waste time. This lady, on the other hand, takes 15 years! Or more!
Are you confused? Have you thought of a question for Helix?
I'm going to put you down for birth pangs. I'm going to make sure your question is in a subcategory though, called from Mr. DA:
1) Thank you for allowing me into this conference hall. It's very nice. I love the food and wine. I'd like to thank the host, first and foremost, for having me as their guest. I would like to know, do you think we could have make a side consulting business for taking companies private?
There, done. Your question is in. You don't even have to show up if you don't want to because i'm going to submit it on paper for you.
Modification to Question 3: I want to know if the convoluted current situation could be consolidated and toxicity removed according to my understanding and theory.
1) A year or so ago, there was mention of a dual listing on the Sedar stock exchange in Canada. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
2) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
3) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. I worry about excessive dilution at these prices, but what is your thoughts on that? Am I looking at it wrong, and how do you see the future in terms of that? Would improved financing be able to consolidate all of the outstanding into one, simple financing package in the future?
4) Would it be fair to say that MJ Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
5) Does Helix have plans to uplist in the future? Akerna (KERN) seems to have gotten on the Nasdaq by way of a SPAC. If so, do you have a plan, as it's my understanding that we do not currently meet the requirements? And would a reverse split ever be considered in such a plan?
6) Can you shed any light on what the sale of the guard side of Helix would mean to your bottom line, and will that be reflected in the next quarter? Do you have a projection of what your gross revenue and margins will look like at years' end without the security business?
7) How much of your revenue is recurring, and what are your recurring growth expectations?
8) In the last 8K in regard to the sale of Helix Security, it's my understanding that Invecta assumes most of its liabilities with the exception of some pending lawsuits against the company. Do I understand that correctly? It also notes that they do not assume "matters referenced in that certain letter dated January 7, 2020, from Michael P. Kane to Grant Whitus regarding a shooting at STEM School Highlands Ranch on May 7, 2019." Could you shed some light on what that's about?
9) There's a 10b5 program in place, which automatically sells insider shares over a period of time, overseen by a neutral party. Some people see those Form 4's and get the wrong message, thinking insiders don't believe in the company. They see a large amount of form 4's, even though the overall tally is small. Are you able to say how long that will continue? I understand that you should reap the fruits of your labor, but just wondering if you feel it may send the wrong messaging out there?
Current Question Tally:
1) A year or so ago, there was mention of a dual listing on the Sedar stock exchange in Canada. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
2) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
3) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. It hurts to see. I worry about excessive dilution at these prices, but what is your thoughts on that? Am I looking at it wrong, and how do you see the future in terms of that?
4) Would it be fair to say that MJ Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
5) Does Helix have plans to uplist in the future? Akerna (KERN) seems to have gotten on the Nasdaq by way of a SPAC. If so, do you have a plan, as it's my understanding that we do not currently meet the requirements? And would a reverse split ever be considered in such a plan?
6) Can you shed any light on what the sale of the guard side of Helix would mean to your bottom line, and will that be reflected in the next quarter? Do you have a projection of what your gross revenue and margins will look like at years' end without the security business?
7) How much of your revenue is recurring, and what are your recurring growth expectations?
8) In the last 8K in regard to the sale of Helix Security, it's my understanding that Invecta assumes most of its liabilities with the exception of some pending lawsuits against the company. Do I understand that correctly? It also notes that they do not assume "matters referenced in that certain letter dated January 7, 2020, from Michael P. Kane to Grant Whitus regarding a shooting at STEM School Highlands Ranch on May 7, 2019." Could you shed some light on what that's about?
9) There's a 10b5 program in place, which automatically sells insider shares over a period of time, overseen by a neutral party. Some people see those Form 4's and get the wrong message, thinking insiders don't believe in the company. They see a large amount of form 4's, even though the overall tally is small. Are you able to say how long that will continue? I understand that you should reap the fruits of your labor, but just wondering if you feel it may send the wrong messaging out there?
I knew it was too good to be true. He's back, despite saying he was leaving. Well, that's par for the course. Just what I expected. Hollow words from this one.
Would you like a chance to be a contribution, Whatsup? Can you put down a question you'd like asked? And I'll translate into English, make it polite, and I'll even make corrections where needed. Perhaps I'll even add some spice of relevance to it.
You never know. Think hard and throw a good question for me. Or, you can ask on the conference call again, but just stay at your table. That's all I ask. And just pretend you don't know me. Don't talk to me. I don't want anyone to think we know each other.
China's Birth Pangs Pt. II
Is the Chinese lady that can't give birth about to go into labor? More birth pangs today.
Like I told Mr. Market in the post I'm responding to, "Don't think I don't have eyes on you. You son of $#@%!! If you want tap water, you are going pay fresh spring French, imported prices! I'm tired of trying to talk logic to you. I OWN YOU!"
Because after I make you partake in the Hong Kong feast, we are going to discuss how your HLIX hand is going to pay for my free shares of KHIRON.
I think HLIX should strike some sort of security deal with Khiron Life Sciences. That's where Vincente Fox resides as well, on their board. They have money and love to burn it, so talk to Vicente Fox! And get him over here!
Okay. And another:
I'll phrase that in a diplomatic way. I feel like they have a legitimate reason to reap rewards from their hard work, but I understand your point on optics. And maybe it can get passed on to other outsiders.
Also, note to self: Add a question about assumed liabilities with the Helix transaction. My understanding is that our pending lawsuits are not assumed. And can you shed light on this quote of the 8k about this non-assumed liability concerning a letter written to Grant Whitus back in January in regard to a Stem High School shooting. What is that all about, if you could elaborate?
I never can think of questions to ask during a meeting. Even in real company meetings. I always think of them after the meeting is over.
This could prove to be a very interesting conference call if they can get to everyone's question.
The Growing List for our Q&A:
I wanted to say in question 5 that KERN got there by nefarious methods through a SPAC, but I'm trying to be nice. I'm practicing for my New Years Resolution coming up.
I merged and consolidated some of KMP's and Global's questions together as there was some overlap.
We can add to this and/or edit before final submission. As a group/team effort. And I intend to present it that way in email, as a group of 3 investors, or whatever that number climbs to, that have presented all their questions in one email. And this can keep the Q&A good with substance for a full hour or whatever time we have if nobody asks questions live. And hopefully that happens too.
And if the answers are good, I can have good fodder to go beat over the heads of KERN shareholders with since they are feeling some pain right now. I'd love to have the opportunity to kick them when they are down. New Years Resolution doesn't start yet...
1) A year or so ago, there was mention of a dual listing on the Sedar exchange. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
2) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
3) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. It hurts to see. I worry about excessive dilution at these prices, but what is your thoughts on that? Am I looking at it wrong, and how do you see the future in terms of that?
4) Would it be fair to say that MJ Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
5) Does Helix have plans to uplist in the future? Akerna (KERN) seems to have gotten on the Nasdaq by way of a SPAC. If so, do you have a plan, as it's my understanding that we do not currently meet the requirements? And would a reverse split ever be considered in such a plan?
6) Can you shed any light on what the sale of the guard side of Helix would mean to to your bottom line, and will that be reflected in the next quarter? Do you have a projection of what your gross revenue and margins will look like at years' end without the security business?
7) How much of your revenue is recurring, and what are your recurring growth expectations?
Great questions, Global. I'll add those to the list tonight. Hopefully have everything submitted by Thursday night.
I hope not on the reverse split. If it would mean uplisting, I'd be okay with it. I dont' believe in the reverse split curse of the fundamentals are there. But for psychological purposes, I'm a definite no-vote there UNLESS it really would give us a uplisting. If it has true benefit.
GOOD QUESTIONS!
Your story still does not add up.
Bought 200k grand worth got screwed and made money back as soon as I leave this board . That will be It. All the best.
--------------------
So, you are on the record as buying this 200k at $2.00 which translates to 100,000 shares. You are on the record at .40 cents as an angry individual, claiming to have taken $200k on the chin.
Now you are saying you shorted at $1.50 and made 600k profit. To make the math simple, let's assume you covered all at 10 cents. Make it a round off clean number of 400,000 shares you shorted at $1.50.
That means at .40 cents as you claim to be angry on the record, predicting a 30 cent price, you could alledgedly cover at $160,000 for a paper gain of $440,000.
Less the $200K you allegedly spent at $2.00 would still be a $200k profit. Yet, you claimed to be angry, which doesn't add up. And then you made accussations on our conference call for what you are allegedly admitting to now. Isn't that fraud and manipulation on your own behalf,IFF were to beliee this new, ever changing, story?
And, we still have no time-stamp of anything. And the shares you allegedly bought, you must still hold. Otherwise, how did you ever come up wtih a $200K loss on a 100,000 share purchase, which you are on the record as affirming?
You are all over the place, you don't add up, you have no supporting evidence of anything, and you have presented us with contradictons galore. The only thing certain is that you lie on the record.
Don't let the door slam on your cahoonies on the way out! Goodbye and good riddance! :)
Although, sadly, I feel like your "last post here" was yet another lie.
So according to your new story, which is always changing, you never "took it on the chin" as you now claim to have made $600k whereas "taking it on the chin" was described by you as losing $200k.
Wouldn't that make you, by definition, a liar? Steady Kicker over there said he believed you, and that he didn't need supporting evidence.
So why would you buy at $2.00 if you are shorting at $1.50 from overseas? How is that logical?
And why would you accuse Zac, in the last conference call, as "shorting" his own stock, when, in fact, you now claim that you are shorting the stock. And IFFFF we did believe this new story, without a shred of supporting evidence, wouldn't that by definition make you an active participant in market manipulation, since you were making accusations on teh written record which you knew were not true, while at the same time shorting the stock and pretending to be angry?
Which story should we believe, if any, from you?
Hi, KMP. Jot your question down exactly as you'd like it asked. I'll make a list. I'm sleepy. I'm going to do some brainstorming here. Add to this rough draft. And I'll add to this list as well over the week as I think of something relevant.
And Whatsup, you can make a contribution too. If you can ask a question here in writing rather than act inappropriately in our conference call, I'd prefer you do that here. And then I'll edit it and make it polite, without changing your meaning. Scouts honor!
And Steady Kicker, if you can -- Well, just do whatever it is you do. Just try not to talk unless absolutely necessary. Grunt if you have to, but just try to focus on the food. Keep it simple.
1) A year or so ago, there was mention of dual listing on the Sedar exchange. Can you explain why that plan was dropped, and do you have any plans to do that in the future?
2) In the last conference call, you said, "We're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call." Would you be able to elaborate on that some?
3) Between July and August, there were 500,000 extra shares added to the OS. I feel like they were from conversions. It hurts to see. I worry about excessive dilution at these prices, but what's is your thoughts on that? Am I look at it wrong, and how do you see the future in terms of that.
4) Would it be fair to say that Mj Freeway and BioTrack are direct competitors? Do you see it that way? And if so, do they win contracts because of lower pricing? It seems to me that their margins are lower, and I'm wondering if that's because they are undercutting you in price. Am I understanding that correctly? Their stock is higher than ours, and I'm wondering what your thoughts are on the reasons behind that.
You faced your demons?
You've given up on your pipe dream of 3 cents? The price you assured us all would happen?
Do you want to apologize to these folks? Especially to Steady Kicker. He looks up to you. That's the perfect example of the question: Who's the bigger fool? The fool that leads or the fool that follows?
Do you want to apologize to him, especially? Because he's very confused. You have betrayed him.
I'd like to see those time stamps please. I have you down for 13 cents at no more than 10,000 shares since I can't get a time stamp.
I'd also like you to sign the following confession letter:
------------------------
I, Whatsup, do hereby declare that I have lied under oath and given false testimony. Such as, but not limited to, "Three cents I say" and several other false prophesies. I have never had $20 million, nor did I ever offer HLIX a large sum of money.
I lied under oath about having a partner that offered $10 million to Helix, then lied again when I changed my false testimony to a story of me, and me alone, offering $10 million. I can't keep my stories straight. I have never offered any supporting evidence to any unsubstantiated claims I made. It's impossible for me to "take it on the chin" while at the same time going short, which would be consistent with my history of pathological lying.
Signed, Yours Truly,
Whatsup
-----------------------------------
If you could cut and paste that, give a /s/ behind your typed signature, I think that will suffice.
Khiron in Hong Kong today
That's a good place for beauty products! Hong Kong has more billionaires than anywhere on the planet. They love to spend money on things that have no purpose. Especially the spoiled female daughters of those billionaires.
They buy expensive purses just to throw into a closet and never see the light of day. So, placebos should do well there!
Come down to 21 cents! I want your production plant, your cannabis plants, and your products. My price, your pain.
I hope that tonight I have time to jot some questions down, Global. I want to bring up the Sedar Canadian exchange. They had talked about a dual listing there last year or the year prior, and then scrapped. I just want to know why and if there are future plans for that.
I'd love your contributions to that list before the week is up. It would be nice to have a long Q&A this time, but quality Q&A.
Conference Call This Friday:
August 14, 2020, and the Company will host a conference call at 4:30 p.m. eastern time on Monday, Aug 17th to discuss the financial results and the Company's positioning for growth for the remainder of 2020 and beyond. There will be a live Q&A following the presentation portion of the call. Investors are also encouraged to submit questions via email prior to and during the call by emailing ir@helixtechnologies.com
First of all, I don't want anyone from the dunce-hat table to talk to me or even look at me. I'm not with y'all. You know who you are. And DON'T TALK this time. If you can't think of anything intelligent to say, then don't say anything at all.
My questions will be presented via email. I may post them here for some imput from INTELLIGENT contributors only. No re-hashing of conspiracy theories needed. If you don't like an answer, move on to greener pastures. Learn how to be polite. Learn how to be nice. Learn proper etiquette. Learn how to talk and how to hold your silverware properly.
I don't know why they just let anyone with a heartbeat in through the doors. For now, we have a public pool. Enjoy it while you can. One day, I hope we graduate to private country club rules and an upgraded stock exchange. One day!!!
OTC Dated 8-4-2020
Outstanding Shares
114,947,768
08/04/2020
So far so good.
https://www.otcmarkets.com/stock/HLIX/security
500,000 shares have diluted us, unexplained to my knowledge. That could explain a lot of that selling. I don't like it, but it's not skyrocketing. But I don't like it either. At $1.00, that would be $500,000. That pays down a lot. That would be life-sustainable acidic levels. At 10 cents, that's $50,000 and doesn't pay down much of anything. We are paying for that. That's theft, like skimming off the till. Legal theft. Personally, I think Scott Ogur should step up and mortgage his home and start repaying the till. And start by apologizing publicly to shareholders for that financing.
I'm glad to see some steps taken to reconfigure some of those convertibles that expired last month. Extending them, and by my interpretation, making them more in alignment to my 11 cents. Wasn't great, but was better. But good for what you can do when you give someone legal authority to put an albatross around your neck.
Glad to see some cash and high margins in the future, which can do battle with the toxic levels. I'd like to see this cleared out and not too much more poisoning of the wells here. That number went up. DON'T LIKE IT. Don't let it go up too much. Don't make me mad.
____________________________________________________________
In the post I'm responding to, I said:
OTC Dated 7-2-20
https://www.otcmarkets.com/stock/HLIX/security
Just for the record, the last update from the transfer agent on HLIX's OS was on 7-2-20, which reads 114,447,768.
On May 20th, the last 10Q said this:
As of May 12, 2020, the registrant had 97,924,212 shares of its common stock, par value $0.001 per share, outstanding.
https://www.otcmarkets.com/filing/html?id=14154906&guid=O9fFUKuv_evUV3h
Toxic conversions this low are extremely dilutive. Hence, toxic. Keep an eye on that number. That's what mgmt. needs to address. If it starts rapidly rising, they punish themselves. They need to address that.
Putting this number on this time-stamp for the next update from the transfer agent. We don't want to see toxicity. I do admit, there is a lot of selling going on here. And it's not from insiders. If that number starts rising without explanation, it's toxic conversions. And our CFO is going to need to be held accountable. That would be theft of shareholders. Debasement. Unintentional or not, matters not.
I don't accept your short position. You have no time-stamped corroboration.
Plus, it doesn't go with your actions. You should be happy. Instead, you've been angry and claimed to have taken it "on the chin."
I will, however, accept your alleged buy today at .13. I'd like to see time-stamps and exact quantity, please. No time stamps at time of execution, then testimony dismissed.
I showed you a pamphlet that goes all the way back to 2006 or so that had his full name on it with picture from a credible source in good company. With link.
Meanwhile, you have supplied nothing. You have all these stories and all these suspicions, yet never offer any supporting evidence. My suspicion is mental illness. This how many with bi-polar disorder interpret things around them. Always paranoia.
You can suspect all you want. If you have no supporting evidence, you have zilch. Nada. If you have stories and no supporting evidence, you have hearsay.
Again, if you suspect the Lunar landing was a hoax, that burden falls on you! The world is full of paranoia and delusions. Religion and ideology are often places these confused minds can turn to to make sense of things. Conspiracy theories are ripe for such minds!
If you have anything, bring it to me. If not, then don't talk.
Once again, for a beginning course on how to interpret the world around you, I suggest Carl Sagan's Baloney Detection Kit. You can't go wrong if you filter everything through that. Consider it your Hitchiker's Guide to the Galaxy. Never leave home without it!
Invecta bought Helix Security for $1.7M
https://www.otcmarkets.com/filing/html?id=14306842&guid=_CU6UF3pD-JCryh
(a) The aggregate consideration for the Assets and the rights and benefits conferred herein (the “Purchase Price”) shall be (i) $1,750,000 (the “Base Purchase Price”), and (ii) the assumption of the Assumed Liabilities.
Looks like they take our security liabilities, but not our pending lawsuits. And I have no idea what this is about: "matters referenced in that certain letter dated January 7, 2020, from Michael P. Kane to Grant Whitus regarding a shooting at STEM School Highlands Ranch on May 7, 2019." They don't inherit that, whatever that is about. The only thing I can find on google is a random shooting at STEM high school from another depraved individual.
That doesn't seem like much. Helix paid less for Tan than I remembered in last post. It was actually $100,000 in cash and 250,000 shares.
I guess it's not enough to brag about. But it's comes on top of that previous $1M we got from accredited investors at 11 cents per share -- restricted shares. It knocks our top line down significantly and brings us to KERN levels (prior to their recent acquisitions). I hope the profitability situation looks good when all the dust clears. I'm too sleepy to really read more right now.
I don't know how KERN can be worth $85 million today. That can't be a true story over there. But if their cash burn continues at this rate, and their integration of their power grabs turns as sour as most disappointments, I don't expect them to have too much more cash than us at this time next year. Not witihout some serious dilution, anyway.
Nice interview with Toler on the sale:
It's interesting they say this:
"Helix will use the net proceeds to pay off existing liabilities and strengthen its working capital position."
I only skimmed it before. That's great! That's what I just finished saying -- that I hope they can consolidate their debt situation this way. I hope this removes our toxic situation. They don't say how much, but if it can pay off ALL long-term liabilities, that would be great.
It's interesting that they purchased TAN a year or so ago. So, it's not really "solidifying a transition" in the implied sense. It's really a shift in strategy if you ask me. A new direction. Higher-margin software. Security the way Blackberry is doing it - my other contrarian tech play. But this one focused on cannabis security. It's no longer the "full suite" but it is security and transport by other means. Hopefully good relations with our new buyer can translate into more business for both parties. We can refer our new business to them for those needs, and vice versa! I'd like to see that.
It was indeed a growing business for HLIX too. Pretty significant on revenues. So, I hope that commanded a good price. It would be really great if this was a step taken to satisfy someone that wants to give us a lot of money at very good terms. I have no idea, but that would be nice.
It continues to be a great adventure, that's for sure. Now we need to replace this lost revenue. With a high-growth focus, I'm hoping... Time to take some KERN business away from KERN.